Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke

Stroke

Volumn 46, Issue 1, 2015, Pages 221-228

  Ramos Cejudo, Jaime ^a   Gutiérrez Fernández, María ^a   Otero Ortega, Laura ^a   Rodríguez Frutos, Berta ^a   Fuentes, Blanca ^a   Vallejo Cremades, Maria Teresa ^a   Hernanz, Teresa Navarro ^b   Cerdán, Sebastián ^b   Díez Tejedor, Exuperio ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

brain derived neurotrophic factor; endothelin 1; subcortical stroke

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; A2B5 PROTEIN; APC PROTEIN; BRAIN PROTEIN; ENDOTHELIN 1; KI 67 ANTIGEN; MYELIN BASIC PROTEIN; OLIGODENDROCYTE MARKER O4; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIFFUSION TENSOR IMAGING; MYELINATION; NONHUMAN; OLIGODENDROGLIA; RAT; REMYELINIZATION; SUBCORTICAL ISCHEMIC STROKE; TRACTOGRAPHY; TREATMENT DURATION; WHITE MATTER INJURY; ANIMAL; BRAIN; COMPLICATION; DRUG EFFECTS; MYELIN SHEATH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; STROKE; WHITE MATTER;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; DIFFUSION TENSOR IMAGING; MAGNETIC RESONANCE IMAGING; MYELIN BASIC PROTEIN; MYELIN SHEATH; OLIGODENDROGLIA; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; STROKE; WHITE MATTER;

EID: 84920277019     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006692     Document Type: Article

References (25)

1. Sozmen EG, Hinman JD, Carmichael ST. Models that matter: white matter stroke models. Neurotherapeutics. 2012;9:349-358.
2. Matute C, Domercq M, Pérez-Samartín A, Ransom BR. Protecting white matter from stroke injury. Stroke. 2013;44:1204-1211.
3. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004;27:589-594.
4. Schäbitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A, et al. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 2007;38:2165-2172.
5. Schäbitz WR, Berger C, Kollmar R, Seitz M, Tanay E, Kiessling M, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke. 2004;35:992-997.
6. Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals. 2010;18:186-202.
7. Cellerino A, Carroll P, Thoenen H, Barde YA. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci. 1997;9:397-408.
8. Vondran MW, Clinton-Luke P, Honeywell JZ, Dreyfus CF. BDNF+/-mice exhibit defcits in oligodendrocyte lineage cells of the basal fore-brain. Glia. 2010;58:848-856.
9. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40:2244-2250.
10. Britton GL, Kim H, Kee PH, Aronowski J, Holland CK, McPherson DD, et al. In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes. Circulation. 2010;122:1578-1587.
11. Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerdán S, et al. Effects of intravenous administration of allogenic bone marrow-and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther. 2013;4:11.
12. Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke. 1997;28:2060-2065.
13. Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res. 1996;36:280-286.
14. Horch HW. Local effects of BDNF on dendritic growth. Rev Neurosci. 2004;15:117-129.
15. Goldberg MP, Ransom BR. New light on white matter. Stroke. 2003;34:330-332.
16. Blasi F, Wei Y, Balkaya M, Tikka S, Mandeville JB, Waeber C, et al. Recognition memory impairments after subcortical white matter stroke in mice. Stroke. 2014;45:1468-1473.
17. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81:871-927.
18. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke. 2007; 38:724-730.
19. Baracskay KL, Kidd GJ, Miller RH, Trapp BD. NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells. Glia. 2007;55:1001-1010.
20. Sommer I, Schachner M. Monoclonal antibodies (O1 to O4) to oligoden-drocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol. 1981;83:311-327.
21. Cui QL, D'Abate L, Fang J, Leong SY, Ludwin S, Kennedy TE, et al. Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate. Stem Cells Dev. 2012;21:1831-1837.
22. Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF. Regionally specifc effects of BDNF on oligodendrocytes. Dev Neurosci. 2003;25:116-126.
23. Cheatwood JL, Emerick AJ, Schwab ME, Kartje GL. Nogo-A expression after focal ischemic stroke in the adult rat. Stroke. 2008;39:2091-2098.
24. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduc-tion. Annu Rev Biochem. 2003;72:609-642.
25. Cai D, Shen Y, De Bellard M, Tang S, Filbin MT. Prior exposure to neu-rotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron. 1999;22:89-101.